MAPT and supranuclear palsy, progressive, 1: They were able to distinguish clinical subtypes of PSP not only according to total tau load but also according to cell‐type (neuronal vs glial) specific patterns of vulnerability across brain regions, which suggested distinct dynamics or circuit‐specific segregation of propagating tau pathologies.